Synergy between chemotherapy and cancer vaccination

Aging

Volumn 7, Issue 6, 2015, Pages 340-341

  van der Sluis, Tetje C ^b   van der Burg, Sjoerd H ^b   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CISPLATIN; MONOCLONAL ANTIBODY; PEPTIDE; TUMOR NECROSIS FACTOR;

ANIMAL; APOPTOSIS; BLOOD; CD8+ T LYMPHOCYTE; DRUG POTENTIATION; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; MOUSE; PAPILLOMAVIRIDAE; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CISPLATIN; DRUG SYNERGISM; HUMANS; IMMUNOTHERAPY; MICE; PAPILLOMAVIRIDAE; PEPTIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84935482034     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100752     Document Type: Editorial

References (7)

1. Melief CJ et al. Nat.Rev.Cancer 2008; 8:351-360.
2. van der Sluis TC et al. Clin.Cancer Res. 2015; 21:781-794.
3. Zhang B et al. Kidney Int. 2007; 72:37-44.
4. Eggermont AM et al. Journal of Clinical Oncology 1996 ; 14:2653-2665.
5. Lejeune FJ et al. Cancer Immun. 2006; 6:6.
6. Schumacher TN et al. Science. 2015; 348:69-74.
7. Gubin MM et al. Nature 2014; 515:577-581.